Latest filings (excl ownership)
8-K
Bankruptcy or Receivership
30 Oct 23
CT ORDER
Confidential treatment order
19 Oct 23
8-K
Termination of a Material Definitive Agreement
16 Oct 23
SC 13E3/A
Going private transaction (amended)
29 Sep 23
PRER14A
Preliminary revised proxy
29 Sep 23
8-K
Entry into a Material Definitive Agreement
20 Sep 23
SC 13E3/A
Going private transaction (amended)
7 Sep 23
PRER14A
Preliminary revised proxy
7 Sep 23
8-K
Regulation FD Disclosure
6 Sep 23
8-K
Departure of Directors or Certain Officers
21 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
SC 13E3
Going private transaction
25 Jul 23
PREM14A
Preliminary proxy related to merger
24 Jul 23
8-K
Departure of Directors or Certain Officers
12 Jul 23
DEFA14A
Additional proxy soliciting materials
30 Jun 23
8-K
Entry into a Material Definitive Agreement
29 Jun 23
DEF 14A
Definitive proxy
26 Jun 23
8-K
Entry into a Material Definitive Agreement
13 Jun 23
8-K
Entry into a Material Definitive Agreement
31 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Entry into a Material Definitive Agreement
3 May 23
25-NSE
Exchange delisting
26 Apr 23
8-K
Departure of Directors or Certain Officers
21 Apr 23
8-K
Departure of Directors or Certain Officers
17 Apr 23
8-K
Regulation FD Disclosure
12 Apr 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Apr 23
8-K
Regulation FD Disclosure
4 Apr 23
EFFECT
Notice of effectiveness
31 Mar 23
EFFECT
Notice of effectiveness
30 Mar 23
POS AM
Prospectus update (post-effective amendment)
28 Mar 23
POS AM
Prospectus update (post-effective amendment)
28 Mar 23
10-K
2022 FY
Annual report
28 Mar 23
8-K
Gelesis Reports Fourth Quarter and Full Year 2022 Results
28 Mar 23
PRE 14A
Preliminary proxy
27 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
3 Mar 23
424B3
Prospectus supplement
2 Mar 23
Latest ownership filings
SC 13D/A
PureTech Health LLC
16 Oct 23
SC 13D/A
PureTech Health LLC
21 Sep 23
4
Change in insider ownership
21 Sep 23
SC 13D/A
PureTech Health LLC
29 Jun 23
4
Change in insider ownership
14 Jun 23
SC 13D/A
PureTech Health LLC
13 Jun 23
4
Change in insider ownership
31 May 23
SC 13D/A
PureTech Health LLC
30 May 23
4
Change in insider ownership
3 May 23
SC 13D/A
PureTech Health LLC
2 May 23
SC 13D/A
PureTech Health LLC
20 Apr 23
SC 13D/A
PureTech Health LLC
4 Apr 23
SC 13D/A
PureTech Health LLC
23 Feb 23
SC 13G/A
PACIFIC INVESTMENT MANAGEMENT CO LLC
14 Feb 23
SC 13G/A
PERISCOPE CAPITAL INC.
13 Feb 23
SC 13G/A
ARISTEIA CAPITAL LLC
10 Feb 23
SC 13D
SSD2, LLC
30 Dec 22
4
RAJU S KUCHERLAPATI
22 Nov 22
SC 13D/A
PureTech Health LLC
4 Aug 22
SC 13G
CMS Medical Venture Investment (HK) Ltd
20 Jul 22
4
RAJU S KUCHERLAPATI
17 Jun 22
4
Alessandro Sannino
13 Jun 22
4
Elaine Chiquette
10 Jun 22
4
Yishai Zohar
9 May 22
4
Jane Wildman
9 May 22
4
Alessandro Sannino
9 May 22
4
Dominic Perks
9 May 22
4
David A. Pass
9 May 22
4
Elliot Maltz
9 May 22
4
Harry L. Leider
9 May 22
4
RAJU S KUCHERLAPATI
9 May 22
4
PAUL R. FONTEYNE
9 May 22
4
Clayton Christopher
9 May 22
4
Elaine Chiquette
9 May 22
4
David Abraham
9 May 22
4
Kathryn Cavanaugh
9 May 22
4
Alison Bauerlein
9 May 22
SC 13G
Capstar Sponsor Group, LLC
22 Feb 22
SC 13G
PERISCOPE CAPITAL INC.
14 Feb 22
SC 13G
MARSHALL WACE, LLP
14 Feb 22